Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of paclitaxel in rats

Phytotherapy Research

Volumn 25, Issue 8, 2011, Pages 1250-1253

  Jin, Jing ^a   Bi, Huichang ^a   Hu, Jinqing ^a   Zeng, Hang ^a   Zhong, Guoping ^a   Zhao, Lizi ^a   Huang, Zhiying ^a   Huang, Min ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

herb drug interaction; paclitaxel; pharmacokinetics; Schisandra sphenanthera extract; Wuzhi tablet

Indexed keywords

ALCOHOL; HERBACEOUS AGENT; PACLITAXEL; PLANT EXTRACT; SCHISANDRA SPHENANTHERA EXTRACT; SCHISANTHERIN A; UNCLASSIFIED DRUG; WUZHI;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; DRUG EXPOSURE; DRUG HALF LIFE; HERB; HERB DRUG INTERACTION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SCHISANDRA SPHENANTHERA; TABLET; TIME TO MAXIMUM PLASMA CONCENTRATION; WUWEIZI;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHINA; DRUGS, CHINESE HERBAL; HERB-DRUG INTERACTIONS; MALE; PACLITAXEL; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SCHISANDRA;

RATTUS; SCHISANDRA SPHENANTHERA;

EID: 80051696071     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3407     Document Type: Article

References (19)

1. Bardelmeijer HA, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O,. 2004. Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice. Invest New Drugs 22: 219-229. (Pubitemid 39012561)
2. Choi BC, Choi JS, Han HK,. 2006. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats. Int J Pharm 323: 81-85.
3. Choi JS, Jo BW, Kim YC,. 2004. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin. Eur J Pharm Biopharm 57: 313-318.
4. Choi JS, Li X,. 2005. The effect of verapamil on the pharmacokinetics of paclitaxel in rats. Eur J Pharm Sci 24: 95-100. (Pubitemid 40051291)
5. Huizing MT, Misser VH, Pieters RC, et al., 1995. Taxanes: a new class of antitumor agents. Cancer Invest 13: 381-404.
6. Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T,. 2004. Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract. Drug Metab Dispos 32: 1351-1358. (Pubitemid 39564554)
7. Jin J, Bi H, Hu J, et al. 2010. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats. Biopharm Drug Dispos 31: 264-268.
8. Kimura Y, Aoki J, Kohno M, Ooka H, Tsuruo T, Nakanishi O,. 2002. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel. Cancer Chemother Pharmacol 49: 322-328. (Pubitemid 34253271)
9. Lai L, Hao H, Wang Q, et al., 2009. Effects of short-term and long-term pretreatment of Schisandra lignans on regulating hepatic and intestinal CYP3A in rats. Drug Metab Dispos 37: 2399-2407.
10. Li X, Choi JS,. 2007. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 337: 188-193. (Pubitemid 46756050)
11. Min HY, Park EJ, Hong JY, et al., 2008. Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells. Bioorg Med Chem Lett 18: 523-526.
12. Qiangrong P, Wang T, Lu Q, Hu X,. 2005. Schisandrin B-a novel inhibitor of P-glycoprotein. Biochem Biophys Res Commun 335: 406-411. (Pubitemid 41140237)
13. Qin XL, Bi HC, Wang CX, et al., 2010a. Study of the effect of Wuzhi tablet (Schisandra sphenanthera extract) on tacrolimus tissue distribution in rat by liquid chromatography tandem mass spectrometry method. Biomed Chromatogr 24: 399-405.
14. Qin XL, Bi HC, Wang XD, et al., 2010b. Mechanistic understanding of the different effects of Wuzhi tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506). Int J Pharm 389: 114-121.
15. Singla AK, Garg A, Aggarwal D,. 2002. Paclitaxel and its formulations. Int J Pharm 235: 179-192. (Pubitemid 34185449)
16. Sparreboom A, van Asperen J, Mayer U, et al., 1997. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94: 2031-2035. (Pubitemid 27113956)
17. Sun M, Xu X, Lu Q, Pan Q, Hu X,. 2007. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1. Cancer Lett 246: 300-307. (Pubitemid 44959402)
18. Yoo HH, Lee M, Lee MW, Lim SY, Shin J, Kim DH,. 2007. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2. Planta Med 73: 444-450. (Pubitemid 46917459)
19. Zhang S, Sagawa K, Arnold RD, Tseng E, Wang X, Morris ME,. 2010. Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo. J Pharm Sci 99: 430-441.